Are you asking about Romidepsin and Duvelisib as a therapy combination for lymphoma?
Based on the available information, Duvelisib (Copiktra) is a PI3K inhibitor — a drug that blocks certain proteins that help lymphoma cells survive. It's approved for people who have already gone through at least two rounds of treatment.
Show Full Answer
Are you asking about Romidepsin and Duvelisib as a therapy combination for lymphoma?
Based on the available information, Duvelisib (Copiktra) is a PI3K inhibitor — a drug that blocks certain proteins that help lymphoma cells survive. It's approved for people who have already gone through at least two rounds of treatment.
However, Romidepsin and Duvelisib as a combined therapy isn't something covered in the current information available here, and it may not be a standard treatment approach for lymphoma. It's really important to speak directly with your oncologist about this combination, as they can:
- Review your specific lymphoma type and history
- Assess whether this combination is appropriate for you
- Discuss any clinical trials that might include this therapy
- Explain potential risks and side effects
Your care team is truly the best resource for personalized treatment decisions. Don't hesitate to ask them questions — no question is too small when it comes to your health! 💙
August 6
Join
Your Privacy Choices
